Press Releases

GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development

ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT™
read more ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT™

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform
read more Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023
read more ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023

ProBioGen’s Growth Strategy Continues Successfully
read more ProBioGen’s Growth Strategy Continues Successfully

Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
read more Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III

ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
read more ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production

ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
read more ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology